N/A
Completed N=21
Effect of Topical Aqueous Suppressants on Intraocular Gas Duration Following Pars Plana Vitrectomy
Macular Hole · Retinal Detachment
Source: ClinicalTrials.gov NCT01257698 ↗
Enrolled (actual)
21
Serious AEs
0.0%
Results posted
Sep 2019
Primary outcomePrimary: Duration of Intraocular Gas — 17.1; 18.1 days
Summary
The purpose of this study is to see if glaucoma eye drops (dorzolamide-timolol) have any effect on the duration of an intraocular gas bubble following pars plana vitrectomy.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Duration of Intraocular Gas |
17.1; 18.1 | — |
Eligibility Criteria
Inclusion Criteria
- Patients scheduled for pars plana vitrectomy with intraocular gas tamponade with sulfur hexafluoride (e.g., retinal detachment, macular hole, other condition at the discretion of the investigator).
- Ability to provide written informed consent and comply with study assessments for the full duration of the study.
Exclusion Criteria
- Prior trabeculectomy or tube shunt surgery.
- Current use of topical aqueous suppressants or other glaucoma medications.
- Aphakia or presence of anterior chamber intraocular lens implant.
- Known allergy or contraindication to sulfa or beta-blocker use (e.g., asthma, chronic obstructive pulmonary disease, bradycardia).
Data sourced from ClinicalTrials.gov (NCT01257698). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.